NCT00140114View on ClinicalTrials.gov

Sublingual Versus Vaginal Misoprostol for Labor Induction at Term

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

September 30, 2006

Conditions
Induction of Labor
Interventions
DRUG

Misoprostol (Cytotec®)

50 micrograms of sublingual or vaginal misoprostol every 4 hours for a maximum of 5 doses

Trial Locations (1)

Unknown

American University of Beirut Medical Center, Beirut

All Listed Sponsors
lead

American University of Beirut Medical Center

OTHER

NCT00140114 - Sublingual Versus Vaginal Misoprostol for Labor Induction at Term | Biotech Hunter | Biotech Hunter